FundaMental Pharma
Small molecule inhibitors for treatment of a range of neurodegenerative diseases
$10.0m
Money raised
Overview
Small molecule inhibitors for treatment of a range of neurodegenerative diseases
- Website:
- Business model: B2B
- Headquarters: Heidelberg
- Social accounts: linkedin
Industries
FundaMental Pharma is active in the following industries: